Massive study of 7,000 preemies aims to save sight

NCT ID NCT07312669

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study looked at over 7,000 premature infants to understand which babies develop a serious eye condition called retinopathy of prematurity (ROP) and need treatment. Researchers used a cloud-based database to compare risk factors and outcomes. The goal was to improve guidelines that protect vision in these vulnerable newborns.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could lead to better screening guidelines that help prevent blindness in premature infants.

What could go wrong

This is an observational study, not a treatment trial, so it cannot directly prove what works best. Results may not apply to all hospitals or regions.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RETINOPATHY OF PREMATURITY (ROP) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Birth Weight Coitus retinopathy of prematurity

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Alaska Children's EYE & Strabismus

    Anchorage, Alaska, 99508, United States